Case Study

Continuous Manufacturing Of Pharmaceuticals

Source: Seeq Corporation

For more than 50 years, pharmaceuticals have been produced via batch manufacturing, which requires multiple steps and the use of large-scale equipment. Recently, however, many in the pharmaceutical industry have begun moving away from batch manufacturing to continuous manufacturing. The FDA is now taking proactive steps to facilitate the drug industry’s implementation of emerging technologies, including continuous manufacturing, to improve product quality and address many of the underlying causes of drug shortages and recalls.

In a continuous manufacturing process, it is often difficult to aggregate data to perform analytics across multiple assets, including process analytical technology (PAT) tools. In addition, continuous monitoring of key performance indicators (KPIs) in near-real time is necessary to maintain the process within the desired design space. KPI monitoring is also needed to enable process adjustments prior to any variables trending outside of the design space.

A pharmaceutical company was finding it difficult to aggregate data and perform analytics across multiple assets, as well as monitor KPIs for continuous pharmaceutical processes in near-real time. The company needed a dashboard to track and monitor the process parameters and identify deviations when they occur. This solution allowed the company’s quality engineers to create a continuously updating operational dashboard to monitor KPIs.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online